Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features
To predict programmed death-ligand 1 (PD-L1) expression of tumor cells in non-small cell lung cancer (NSCLC) patients by using a radiomics study based on CT images and clinicopathologic features. A total of 390 confirmed NSCLC patients who performed chest CT scan and immunohistochemistry (IHC) exami...
Uloženo v:
| Vydáno v: | Journal of X-ray science and technology Ročník 28; číslo 3; s. 449 |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Netherlands
01.01.2020
|
| Témata: | |
| ISSN: | 1095-9114, 1095-9114 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | To predict programmed death-ligand 1 (PD-L1) expression of tumor cells in non-small cell lung cancer (NSCLC) patients by using a radiomics study based on CT images and clinicopathologic features.
A total of 390 confirmed NSCLC patients who performed chest CT scan and immunohistochemistry (IHC) examination of PD-L1 of lung tumors with clinic data were collected in this retrospective study, which were divided into two cohorts namely, training (n = 260) and validation (n = 130) cohort. Clinicopathologic features were compared between two cohorts. Lung tumors were segmented by using ITK-snap kit on CT images. Total 200 radiomic features in the segmented images were calculated using in-house texture analysis software, then filtered and minimized by least absolute shrinkage and selection operator (LASSO) regression to select optimal radiomic features based on its relevance of PD-L1 expression status in IHC results and develop radiomics signature. Radiomics signature and clinicopathologic risk factors were incorporated to develop prediction model by using multivariable logistic regression analysis. The receiver operating characteristic (ROC) curves were generated and the areas under the curves (AUC) were reckoned to predict PD-L1 expression in both training and validation cohorts.
In 200 extracted radiomic features, 9 were selected to develop radiomics signature. In univariate analysis, PD-L1 expression of lung tumors was significantly correlated with radiomics signature, histologic type, and histologic grade (p < 0.05, respectively). However, PD-L1 expression was not correlated with gender, age, tumor location, CEA level, TNM stage, and smoking (p > 0.05). For prediction of PD-L1 expression, the prediction model that combines radiomics signature and clinicopathologic features resulted in AUCs of 0.829 and 0.848 in the training and validation cohort, respectively.
The prediction model that incorporates the radiomics signature and clinical risk factors has potential to facilitate the individualized prediction of PD-L1 expression in NSCLC patients and identify patients who can benefit from anti-PD-L1 immunotherapy. |
|---|---|
| AbstractList | To predict programmed death-ligand 1 (PD-L1) expression of tumor cells in non-small cell lung cancer (NSCLC) patients by using a radiomics study based on CT images and clinicopathologic features.
A total of 390 confirmed NSCLC patients who performed chest CT scan and immunohistochemistry (IHC) examination of PD-L1 of lung tumors with clinic data were collected in this retrospective study, which were divided into two cohorts namely, training (n = 260) and validation (n = 130) cohort. Clinicopathologic features were compared between two cohorts. Lung tumors were segmented by using ITK-snap kit on CT images. Total 200 radiomic features in the segmented images were calculated using in-house texture analysis software, then filtered and minimized by least absolute shrinkage and selection operator (LASSO) regression to select optimal radiomic features based on its relevance of PD-L1 expression status in IHC results and develop radiomics signature. Radiomics signature and clinicopathologic risk factors were incorporated to develop prediction model by using multivariable logistic regression analysis. The receiver operating characteristic (ROC) curves were generated and the areas under the curves (AUC) were reckoned to predict PD-L1 expression in both training and validation cohorts.
In 200 extracted radiomic features, 9 were selected to develop radiomics signature. In univariate analysis, PD-L1 expression of lung tumors was significantly correlated with radiomics signature, histologic type, and histologic grade (p < 0.05, respectively). However, PD-L1 expression was not correlated with gender, age, tumor location, CEA level, TNM stage, and smoking (p > 0.05). For prediction of PD-L1 expression, the prediction model that combines radiomics signature and clinicopathologic features resulted in AUCs of 0.829 and 0.848 in the training and validation cohort, respectively.
The prediction model that incorporates the radiomics signature and clinical risk factors has potential to facilitate the individualized prediction of PD-L1 expression in NSCLC patients and identify patients who can benefit from anti-PD-L1 immunotherapy. To predict programmed death-ligand 1 (PD-L1) expression of tumor cells in non-small cell lung cancer (NSCLC) patients by using a radiomics study based on CT images and clinicopathologic features.PURPOSETo predict programmed death-ligand 1 (PD-L1) expression of tumor cells in non-small cell lung cancer (NSCLC) patients by using a radiomics study based on CT images and clinicopathologic features.A total of 390 confirmed NSCLC patients who performed chest CT scan and immunohistochemistry (IHC) examination of PD-L1 of lung tumors with clinic data were collected in this retrospective study, which were divided into two cohorts namely, training (n = 260) and validation (n = 130) cohort. Clinicopathologic features were compared between two cohorts. Lung tumors were segmented by using ITK-snap kit on CT images. Total 200 radiomic features in the segmented images were calculated using in-house texture analysis software, then filtered and minimized by least absolute shrinkage and selection operator (LASSO) regression to select optimal radiomic features based on its relevance of PD-L1 expression status in IHC results and develop radiomics signature. Radiomics signature and clinicopathologic risk factors were incorporated to develop prediction model by using multivariable logistic regression analysis. The receiver operating characteristic (ROC) curves were generated and the areas under the curves (AUC) were reckoned to predict PD-L1 expression in both training and validation cohorts.MATERIALS AND METHODSA total of 390 confirmed NSCLC patients who performed chest CT scan and immunohistochemistry (IHC) examination of PD-L1 of lung tumors with clinic data were collected in this retrospective study, which were divided into two cohorts namely, training (n = 260) and validation (n = 130) cohort. Clinicopathologic features were compared between two cohorts. Lung tumors were segmented by using ITK-snap kit on CT images. Total 200 radiomic features in the segmented images were calculated using in-house texture analysis software, then filtered and minimized by least absolute shrinkage and selection operator (LASSO) regression to select optimal radiomic features based on its relevance of PD-L1 expression status in IHC results and develop radiomics signature. Radiomics signature and clinicopathologic risk factors were incorporated to develop prediction model by using multivariable logistic regression analysis. The receiver operating characteristic (ROC) curves were generated and the areas under the curves (AUC) were reckoned to predict PD-L1 expression in both training and validation cohorts.In 200 extracted radiomic features, 9 were selected to develop radiomics signature. In univariate analysis, PD-L1 expression of lung tumors was significantly correlated with radiomics signature, histologic type, and histologic grade (p < 0.05, respectively). However, PD-L1 expression was not correlated with gender, age, tumor location, CEA level, TNM stage, and smoking (p > 0.05). For prediction of PD-L1 expression, the prediction model that combines radiomics signature and clinicopathologic features resulted in AUCs of 0.829 and 0.848 in the training and validation cohort, respectively.RESULTSIn 200 extracted radiomic features, 9 were selected to develop radiomics signature. In univariate analysis, PD-L1 expression of lung tumors was significantly correlated with radiomics signature, histologic type, and histologic grade (p < 0.05, respectively). However, PD-L1 expression was not correlated with gender, age, tumor location, CEA level, TNM stage, and smoking (p > 0.05). For prediction of PD-L1 expression, the prediction model that combines radiomics signature and clinicopathologic features resulted in AUCs of 0.829 and 0.848 in the training and validation cohort, respectively.The prediction model that incorporates the radiomics signature and clinical risk factors has potential to facilitate the individualized prediction of PD-L1 expression in NSCLC patients and identify patients who can benefit from anti-PD-L1 immunotherapy.CONCLUSIONThe prediction model that incorporates the radiomics signature and clinical risk factors has potential to facilitate the individualized prediction of PD-L1 expression in NSCLC patients and identify patients who can benefit from anti-PD-L1 immunotherapy. |
| Author | Ge, Yuxi Duan, Shaofeng Li, Yonggang Hu, Chunhong Sun, Zongqiong Hu, Shudong Wang, Jun Song, Jiayang |
| Author_xml | – sequence: 1 givenname: Zongqiong surname: Sun fullname: Sun, Zongqiong organization: Department of Radiology, Affiliated Hospital of Jiangnan University, Wuxi City, Jiangsu Province, China – sequence: 2 givenname: Shudong surname: Hu fullname: Hu, Shudong organization: Department of Radiology, Affiliated Hospital of Jiangnan University, Wuxi City, Jiangsu Province, China – sequence: 3 givenname: Yuxi surname: Ge fullname: Ge, Yuxi organization: Department of Radiology, Affiliated Hospital of Jiangnan University, Wuxi City, Jiangsu Province, China – sequence: 4 givenname: Jun surname: Wang fullname: Wang, Jun organization: Shanghai Institute for Advanced Communication and Data Science, School of Communication and Information Engineering, Shanghai University, Shanghai, China – sequence: 5 givenname: Shaofeng surname: Duan fullname: Duan, Shaofeng organization: General Electric (GE) Healthcare China, Shanghai, China – sequence: 6 givenname: Jiayang surname: Song fullname: Song, Jiayang organization: General Electric (GE) Healthcare China, Shanghai, China – sequence: 7 givenname: Chunhong surname: Hu fullname: Hu, Chunhong organization: Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, China – sequence: 8 givenname: Yonggang surname: Li fullname: Li, Yonggang organization: Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32176676$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkMtKxDAUhoOMOBfd-ACSpZtqLk3aLmW8woCiI7graXI6E2mT2rTgvIDPbcQR3JwbHz__f-Zo4rwDhE4pueCM88u3l3XCCJEpO0AzSgqRFJSmk3_zFM1DeCeEUpHnR2jKGc2kzOQMfT0rY31rdcBhGM0O177HXQ_G6sG6DR62gOEzHkKw3mFf46frZEWxdTi6SEKrmgZriKUZI66V09DjSgUwOPLLNbat2kDAyhmsG-us9p0atr7xG6txDWoYo_gxOqxVE-Bk3xfo9fZmvbxPVo93D8urVaJ5LoYESMEYj7GoIanOKEiSSl1UWqgKRMqLOpcihzoTWa5TI0ncTc2Bcp7xVDO2QOe_ul3vP0YIQ9na8GNfOfBjKBnP8vimnIuInu3RsWrBlF0fk_S78u937BtgB3H1 |
| CitedBy_id | crossref_primary_10_3233_XST_211096 crossref_primary_10_3389_fonc_2021_789014 crossref_primary_10_1093_oncolo_oyac036 crossref_primary_10_1007_s00261_022_03709_9 crossref_primary_10_3389_fimmu_2024_1434171 crossref_primary_10_3389_fonc_2022_986579 crossref_primary_10_1007_s11547_021_01399_9 crossref_primary_10_3233_XST_200730 crossref_primary_10_1088_2057_1976_ac4d43 crossref_primary_10_1109_JBHI_2023_3309840 crossref_primary_10_3233_XST_230189 crossref_primary_10_3233_THC_241079 crossref_primary_10_3389_fonc_2021_729371 crossref_primary_10_1007_s00432_022_04357_8 crossref_primary_10_1111_1754_9485_13426 crossref_primary_10_1111_1759_7714_14620 crossref_primary_10_3233_XST_221191 crossref_primary_10_1007_s11060_023_04367_7 |
| ContentType | Journal Article |
| DBID | NPM 7X8 |
| DOI | 10.3233/XST-200642 |
| DatabaseName | PubMed MEDLINE - Academic |
| DatabaseTitle | PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Engineering Physics |
| EISSN | 1095-9114 |
| ExternalDocumentID | 32176676 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- --K 0R~ 1B1 1RT 1~5 29L 4.4 4G. 53G 5GY 5VS 7-5 AACTN AAEDT AAFNC AALRI AAQFI AAQXI AAQXK AAXUO ABDBF ABEFU ABJNI ABMAC ABUBZ ABUJY ABWVN ACGFS ACPQW ACRPL ACUHS ADBBV ADMUD ADNMO ADZMO AENEX AFFNX AFRHK AGIAB AHDMH AHHHB AITUG AJNRN AKRWK ALMA_UNASSIGNED_HOLDINGS CAG COF CS3 DM4 DU5 EAD EAP EBD EBS EJD EMK EMOBN EPL EST ESX F5P FDB FEDTE FGOYB FIRID G-2 HEI HMK HMO HVGLF HZ~ I-F IHE IL9 IOS J8X LG5 M29 MET MIO MV1 NGNOM NPM O-L O9- P2P Q1R R2- RIG ROL RPZ SAE SAUOL SFC SSZ SV3 TUS UHS WUQ XPP 7X8 AAPII ABJZC AJGYC ARTOV H13 SCNPE |
| ID | FETCH-LOGICAL-c385t-e092231091d04c71e6046c9bc5abe5439f8658ef7578c4d60f86df3e133734c22 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 52 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000541717200006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1095-9114 |
| IngestDate | Sat Sep 27 16:56:12 EDT 2025 Thu Apr 03 07:06:36 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | CT radiomics prediction model Lung cancer PD-L1 immunotherapy |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c385t-e092231091d04c71e6046c9bc5abe5439f8658ef7578c4d60f86df3e133734c22 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 32176676 |
| PQID | 2378001835 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2378001835 pubmed_primary_32176676 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-01-01 |
| PublicationDateYYYYMMDD | 2020-01-01 |
| PublicationDate_xml | – month: 01 year: 2020 text: 2020-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Journal of X-ray science and technology |
| PublicationTitleAlternate | J Xray Sci Technol |
| PublicationYear | 2020 |
| SSID | ssj0011588 |
| Score | 2.3984854 |
| Snippet | To predict programmed death-ligand 1 (PD-L1) expression of tumor cells in non-small cell lung cancer (NSCLC) patients by using a radiomics study based on CT... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 449 |
| Title | Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/32176676 https://www.proquest.com/docview/2378001835 |
| Volume | 28 |
| WOSCitedRecordID | wos000541717200006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEB7apC3poY9Nm0cfTKFXEa_kh3wKJWnIIVmWdgt7W_SEhY29Xaehv6C_OzOyQ3IpFHoxGGSQpdHok2bm-wA-EwIwKtrA4i5W5FE7YZWxona1D87q0gafxCaqyUTP5_V0uHDrhrTKO5-YHLVvHd-RH0lVaVaQU8Xx-qdg1SiOrg4SGo9hWxGUYauu5vdRhHGh-1K4pEc4znt6UiWVOpp_n7GBlCzR_jdombaYs5f_27lX8GIAl_ilt4bX8Cg0I3j-gHJwBM8uh2D6CJ6m7E_X7cKfb8YvuTy5w0Q3i4Rkcb3hlpwVjQQSMfweUmYbbCNOT8XFGJcNNm0juiuzWiGHAHBFvgMdW9IGeYP0SO1PZri8Ir_VoWk89rWYLUsh944XY0jsot0b-HH2dXZyLgaBBuGULq5FyGopE7Woz3JXjUNJp21XW1cYGwqCOlETwAmROfNd7suM3n1Ugc7FlcqdlG9hi7oZ9gG1lzGz3pc8TzFUtcszYwjbFbmspDYH8Olu5Be0APiXTBPaX93ifuwPYK-fvsW6Z-pYKMn8l1V5-A9fv4MdyWfpdL3yHrYjLf_wAZ64m-tlt_mYLIuek-nlLQUw2ZM |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Radiomics+study+for+predicting+the+expression+of+PD-L1+in+non-small+cell+lung+cancer+based+on+CT+images+and+clinicopathologic+features&rft.jtitle=Journal+of+X-ray+science+and+technology&rft.au=Sun%2C+Zongqiong&rft.au=Hu%2C+Shudong&rft.au=Ge%2C+Yuxi&rft.au=Wang%2C+Jun&rft.date=2020-01-01&rft.eissn=1095-9114&rft.volume=28&rft.issue=3&rft.spage=449&rft_id=info:doi/10.3233%2FXST-200642&rft_id=info%3Apmid%2F32176676&rft_id=info%3Apmid%2F32176676&rft.externalDocID=32176676 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1095-9114&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1095-9114&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1095-9114&client=summon |